Aarti Industries Shares Soar 6% on Securing $150 Million Contract 

3 hours ago 21

March 12, 2026March 12, 2026

Shares of Aarti Industries Ltd soared 6% on 12 March after the company secured a multi-year supply deal worth around $150 million with a major agricultural business for the delivery of a vital crop protection intermediate.

In an exchange filing, the specialty chemicals maker stated that the agreement will last until 31 March 2030, transforming an existing yearly engagement into a structured medium-term supply contract with increased quantities.

According to the deal, Aarti Industries will manufacture and supply a vital agrochemical intermediate utilized in crop-protection formulations for global agricultural markets.

CEO Suyog Kotecha commented on the development, saying the deal strengthens the company’s position as a trusted partner to worldwide agrochemical innovation.

According to the corporation, the contract is estimated to generate around $150 million in income over the course of the agreement.

“The agreement enhances our long-term earnings visibility and reflects continued progress in strengthening our speciality chemicals portfolio through high-value, sustainable partnerships,” Kotecha added.

According to Aarti Industries, the deal is expected to promote increased capacity utilisation and volumes without the need for further capital expenditure.

The business also stated that global demand for agricultural intermediates is high, driven by the need for crop-protection solutions and an increased desire for dependable, integrated suppliers.

Aarti Industries reported an almost three-fold increase in net profit for the December quarter, reaching Rs 133 crore from Rs 46 crore in Q3FY25. Revenue increased 26% year on year to Rs 2,319 crore from Rs 1,843 crore in the previous period.

At 2:55 pm, the shares of Aarti Industries were trading 5.10% higher at Rs 452.10 on NSE. 

Tired of missing hot stocks? Tradz by EquityPandit provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!

Read Entire Article